Association of hemoglobin H (HbH) disease with hemoglobin A
diabetes mellitus
glycated albumin
hemoglobin A1c
hemoglobin H disease
Journal
Clinical chemistry and laboratory medicine
ISSN: 1437-4331
Titre abrégé: Clin Chem Lab Med
Pays: Germany
ID NLM: 9806306
Informations de publication
Date de publication:
26 05 2021
26 05 2021
Historique:
received:
20
10
2020
accepted:
15
12
2020
pubmed:
9
2
2021
medline:
19
1
2022
entrez:
8
2
2021
Statut:
epublish
Résumé
Hemoglobin A HbA Significant lower levels of HbA GA but not HbA
Identifiants
pubmed: 33554549
doi: 10.1515/cclm-2020-1563
pii: cclm-2020-1563
doi:
Substances chimiques
Glycated Hemoglobin A
0
Glycation End Products, Advanced
0
Hemoglobin, Sickle
0
Serum Albumin
0
hemoglobin AS
52012-19-8
Hemoglobin H
9034-79-1
Glycated Serum Albumin
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1127-1132Informations de copyright
© 2021 Walter de Gruyter GmbH, Berlin/Boston.
Références
Diabetes Control Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–86.
UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 1998;352:837–53.
American Diabetes Association. Standards of medical care in diabetes–2011. Diabetes Care 2011;34:S11–61.
Fitzgibbons, JF, Koler, RD, Jones, RT. Red cell age-related changes of hemoglobins AIa+b and AIc in normal and diabetic subjects. J Clin Invest 1976;58:820–4.
Koga, M, Morita, S, Saito, H, Mukai, M, Kasayama, S. Association of erythrocyte indices with glycated haemoglobin in pre-menopausal women. Diabet Med 2007;24:843–7.
Koga, M, Hashimoto, K, Murai, J, Saito, H, Mukai, M, Ikegame, K, et al.. Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia. Clin Chim Acta 2011;412:253–7.
Fucharoen, S, Viprakasit, V. Hb H disease: clinical course and disease modifiers. Hematology Am Soc Hematol Educ Program 2009;26–34. https://doi.org/10.1182/asheducation-2009.1.2620008179.
Piel, FB, Weatherall, DJ. The α-thalassemias. N Engl J Med 2014;371:1908–16.
Chui, DH. Alpha-thalassemia: Hb H disease and Hb Barts hydrops fetalis. Ann N Y Acad Sci 2005;1054:25–32.
Laosombat, V, Viprakasit, V, Chotsampancharoen, T, Wongchanchailert, M, Khodchawan, S, Chinchang, W, et al.. Clinical features and molecular analysis in Thai patients with HbH disease. Ann Hematol 2009;88:1185–92.
Cohen, RM, Franco, RS, Khera, PK, Smith, EP, Lindsell, CJ, Ciraolo, PJ, et al.. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008;112:4284–91.
Rhea, JM, Molinaro, R. Pathology consultation on HbA(1c) methods and interferences. Am J Clin Pathol 2014;141:5–16.
Bry, L, Chen, PC, Sacks, DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem 2001;47:153–63.
Desmons, A, Jaisson, S, Leroy, N, Gillery, P, Guillard, E. Labile glycated haemoglobin and carbamylated haemoglobin are still critical points for HbA1c measurement. Biochem Med 2017;27:378–86.
Xu, A, Chen, W, Xia, Y, Zhou, Y, Ji, L. Effects of common hemoglobin variants on HbA1c measurements in China: results for α- and β-globin variants measured by six methods. Clin Chem Lab Med 2018;56:1353–61.
Panzer, S, Kronik, G, Lechner, K, Bettelheim, P, Neumann, E, Dudczak, R. Glycosylated hemoglobins (GHb): an index of red cell survival. Blood 1982;59:1348–50.
Kameyama, M, Takeuchi, S, Ishii, S. Steady-state relationship between average glucose, HbA1c and RBC lifespan. J Theor Biol 2018;447:111–7.
Rohlfing, C, Hanson, S, Weykamp, C, Siebelder, C, Higgins, T, Molinaro, R, et al.. Effects of hemoglobin C, D, E and S traits on measurements of hemoglobin A1c by twelve methods. Clin Chim Acta 2016;455:80–3.
Miyamoto, H, Tao, X, Kohzuma, T, Ohnishi, A. Influences of anemia, kidney disease, thyroid dysfunction, and liver disease on the ratio of glycated albumin to hemoglobin A1c. J Diabetes Sci Technol 2018;12:1082–3.
Little, RR, La’ulu, SL, Hanson, SE, Rohlfing, CL, Schmidt, RL. Effects of 49 different rare Hb variants on HbA1c measurement in eight methods. J Diabetes Sci Technol 2015;9:849–56.
Weykamp, C, Kemna, E, Leppink, S, Siebelder, C. Glycation rate of haemoglobins S, C, D, E, J and G, and analytical interference on the measurement of HbA1c with affinity chromatography and capillary electrophoresis. Clin Chem Lab Med 2015;53:207–10.
Shapiro, R, McManus, MJ, Zalut, C, Bunn, HF. Sites of nonenzymatic glycosylation of human hemoglobin A. J Biol Chem 1980;255:3120–7.
Kabytaev, K, Connolly, S, Rohlfing, CL, Sacks, DB, Stoyanov, AV, Little, RR. Higher degree of glycation of hemoglobin S compared to hemoglobin A measured by mass spectrometry: potential impact on HbA1c testing. Clin Chim Acta 2016;458:40–3.
Roberts, NB, Amara, AB, Morris, M, Green, BN. Long-term evaluation of electrospray ionization mass spectrometric analysis of glycated hemoglobin. Clin Chem 2001;47:316–21.
Xu, A, Xie, W, Wang, Y, Ji, L. Potential of MALDI-TOF mass spectrometry to overcome the interference of hemoglobin variants on HbA1c measurement. Clin Chem Lab Med 2021;59:233–9. https://doi.org/10.1515/cclm-2020-0724.
Lacy, ME, Wellenius, GA, Sumner, AE, Correa, A, Carnethon, MR, Liem, RI, et al.. Association of sickle cell trait with hemoglobin A1c in African Americans. JAMA 2017;317:507–15.